[flash news] on September 6, 2018, European Science funders banned recipients from publishing articles in paid journals

Eleven European foundations have put pressure on European Science funders to ban recipients from publishing in paid journals because of the slow pace of open access (OA) in science publishing By 2020, IMF has invested about 7.6 billion euros in scientific research every year, and they require that every paper published by the fund can be obtained free of charge from the time of publication In a statement, the Fund said it would not allow subscriptions to journals to delay open access to papers for six to 12 months The move means recipients of these funds must give up publishing in thousands of journals unless they change their business models, including the top journals Nature, science, cell and the lancet Http:// research results confirm that the lancet, the world's top authoritative medical journal of China's program to solve the world's cardiovascular problems, has published the full text of Firehawk independently developed by China The results of a large-scale clinical trial of rapamycin targeted eluting stent system (hereinafter referred to as "Flamingo stent") in Europe have solved a major problem that has plagued the field of cardiovascular intervention for more than 10 years in the world This is the first time in nearly 200 years since the founding of the lancet that China's medical devices have appeared, marking that the Huoying stent, which is completely independently developed and produced by Chinese enterprises, has become the leader of a new generation of heart stent industry standards in the world Https:// 2818% 2931768-9 / fulltext: a major team has synthesized apomycin for the first time, which can deal with superbugs Recently, Professor He Yun's team from school of pharmacy, Chongqing University has realized the world's first full synthesis of three apomycin compounds, which was published in nature communication on the 4th Professor He Yun led a team to study the synthesis of apomycin six years ago In the second half of last year, they successfully synthesized the three compounds of apomycin δ 1, δ 2 and ε for the first time, and tested their activity respectively It was found that they have different antibacterial activities Among them, apomycin δ 2 showed excellent antibacterial activity, and its minimum inhibitory concentration was generally lower than ciprofloxacin, vancomycin and penicillin, which were being used in the market It was also resistant to MRSA (methicillin-resistant Staphylococcus aureus) also has good inhibitory activity, and its antibacterial activity against Streptococcus pneumoniae reaches the level of nanogram per milliliter Https:// ovarian cancer treatment has entered the target era In the past 10 years, the incidence rate of ovarian cancer has increased by 30%, the mortality rate has increased by 18%, and the 5 year survival rate has been only 39% AstraZeneca (China) and methadone (China) have jointly announced that the State Administration of market supervision and administration has officially approved the first PARP inhibitor, Lipitor (olaparide tablet), for the maintenance treatment of platinum sensitive recurrent ovarian cancer, whether or not the patient carries BRCA mutation Professor Martin, academician of the Chinese Academy of engineering, said that with the approval of the first PARP inhibitor in China, ovarian cancer treatment will enter a targeted era Http://news.scienceet.cn/sbhtmlnews/2018/9/338893.shtm Audi electric suve Tron started mass production Audi e-tron officially put into mass production As Audi's first mass-produced pure electric SUV, e-tron uses a fast charging facility with a power of 150 kW, which can be charged in about 30 minutes, with a maximum range of more than 500 km Audi will present the electric vehicle at the global premiere in San Francisco on September 17 https://